N1 was administered intraperitoneally (IP)
Retatrutide may be worth waiting for if: You have not responded adequately to existing GLP-1 medications Your obesity is severe enough to benefit from the additional weight loss potential You have metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD) You are comfortable with a medication that has less real-world safety data You can wait for FDA approval without significant health deterioration Your cardiovascular status has been evaluated and heart rate increases are not contraindicated Retatrutide represents the next frontier
Cold Compresses and Temperature Therapy Cold constricts blood vessels and numbs nerve endings, providing immediate relief
Glutathione therapy contributes to speeding up cell turnover, replacing the damaged cells that give a darker appearance to the skin with the new cells
Aging 2 , 742755 (2022)
Many thanks to the valuable co-authors of this paper: Wajd Alkabbani, Julie Paik, Katsiaryna Bykov, Ali Tavakkoli, Robert Glynn, Phyo Htoo, Elaine Yu, Gianluca Trifir, Deborah J